Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.23 USD | +1.09% | -6.36% | -9.77% |
May. 09 | Earnings Flash (INMB) INMUNE BIO Reports Q1 Revenue $14,000 | MT |
May. 09 | Transcript : INmune Bio, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.77% | 200M | |
+12.11% | 116B | |
+12.56% | 106B | |
-10.05% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.59% | 16.33B | |
+6.03% | 14.14B | |
+29.76% | 12.02B |
- Stock Market
- Equities
- INMB Stock
- News INmune Bio, Inc.
- INmune Bio Alzheimer's Treatment Remains on Clinical Hold After FDA Requests Information; Shares Slump After Hours